# Panelists who voted yes said they did not have to consider the lack of robust clinical data.
*Canonical page:* https://truthscore.com/claim/panelists-who-voted-yes-said-they-did-not-have-to-consider-the-lack-of--dbf95f57
*Numbers under lens:* **Evidence-weighted** (`log-odds@1`)
*Machine twins:* https://truthscore.com/claim/panelists-who-voted-yes-said-they-did-not-have-to-consider-the-lack-of--dbf95f57.md · JSON at https://truthscore.com/api/v1
Panelists who voted yes said they did not have to consider the lack of robust clinical data.

## Voices

*Counted, never weighed.*

- [STAT](https://truthscore.com/entity/386551b8) — independent

## Sources

- [FDA advisory panel narrowly rejects compounding of one peptide, backs two others](https://truthscore.com/source/a99385d6)